Reducing Plasma Glucose Effect of Cinnamon in Type 2 Diabetic Patients in the Municipality of Comasagua

Summary

The aim of the study is evaluate the effect of cinnamon powder (Cinnamomum verum) on the glycaemia and HbA1c (Glycohemoglobin) of type 2 diabetic Salvadoran patients, whose hypoglycemic treatment is only Metformin. To carry out this objective, subjects who agree to be part of the study will subjected to measurements of their body weight, height, body mass index, waist circumference, systolic pressure, diastolic pressure, capillary glucose (with glucose meter) every 2 weeks, and their glycohemoglobin (HbA1c) at the beginning and at the end of the study.

Conditions

• Type 2 Diabetes Mellitus

Interventions

DIETARY_SUPPLEMENT

Cinnamon

Participants in this group will receive cinnamon capsules for 12 weeks period. With a 2 g dose in capsules with 500 mg of cinnamon powder (Cinnamomum verum), 1 g in during the breakfast (2 capsules) and the other 1 g (2 capsules) during the dinner.

DIETARY_SUPPLEMENT

Wheat Flour

Participants in this group will receive placebo capsules for 12 weeks period. With a 2 g dose in capsules with 500 mg of wheat flour(fortified with iron, niacin, thiamin, riboflavin and folic acid), 1 g in during the breakfast (2 capsules) and the other 1 g (2 capsules) during the dinner.

Sponsors & Collaborators

• Hospital Nacional Rosales

  collaborator OTHER

• Unidad Comunitaria de Salud Familiar Intermedia de Comasagua (UCSFI-Comasagua)

  collaborator UNKNOWN

• Asociación Salvadoreña de Diabetes (ASADI)

  collaborator UNKNOWN

• Universidad Dr. José Matías Delgado

  lead OTHER

Principal Investigators

• Miguel A Padilla, M.D. · Universidad Dr. José Matías Delgado

• Ana E Centeno, M.D. · Universidad Dr. José Matías Delgado

• Melissa V Abarca, M.D. · Universidad Dr. José Matías Delgado

• Roberto W Cerritos, M.D. · Universidad de El Salvador, Hospital Nacional Rosales

• William A Hoyos, M.D. · Universidad Dr. José Matías Delgado

• Karla M Navarrete, M.D., MPh. · Secretaría Antidrogas de la Ciudad de San Salvador

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-03-01

Primary Completion

2018-05-23

Completion

2018-05-23

Countries

• El Salvador

Study Locations